NDC 49281-590 – MenQuadfi

Neisseria Meningitidis Group A Capsular Polysaccharide Tetanus Toxoid Conjugate Antigen 10 ug/.5mL; Neisseria Meningitidis Group C Capsular Polysaccharide… · Injection, Solution · Intramuscular

Vaccine

Product NDC49281-590

Product details

Brand name
MenQuadfi
Generic name
NEISSERIA MENINGITIDIS GROUP A CAPSULAR POLYSACCHARIDE TETANUS TOXOID CONJUGATE ANTIGEN, NEISSERIA MENINGITIDIS GROUP C CAPSULAR POLYSACCHARIDE TETANUS TOXOID CONJUGATE ANTIGEN, NEISSERIA MENINGITIDIS GROUP Y CAPSULAR POLYSACCHARIDE TETANUS TOXOID CONJUGATE ANTIGEN, and NEISSERIA MENINGITIDIS GROUP W-135 CAPSULAR POLYSACCHARIDE TETANUS TOXOID CONJUGATE ANTIGEN
Labeler
Sanofi Vaccines US Inc.
Dosage form
Injection, Solution
Route
Intramuscular
Marketing category
BLA · BLA125701
Marketed since
April 23, 2020
Listing expires
December 31, 2027

Active ingredients

Package NDC codes (3)

Package NDCDescriptionSince
49281-590-011 VIAL, SINGLE-DOSE in 1 CARTON (49281-590-01) / .5 mL in 1 VIAL, SINGLE-DOSE (49281-590-58)Apr 23, 2020
49281-590-055 VIAL, SINGLE-DOSE in 1 CARTON (49281-590-05) / .5 mL in 1 VIAL, SINGLE-DOSE (49281-590-58)Apr 23, 2020
49281-590-1010 VIAL, SINGLE-DOSE in 1 CARTON (49281-590-10) / .5 mL in 1 VIAL, SINGLE-DOSE (49281-590-58)Apr 23, 2020

Other Menquadfi products